Video game physio for duchenne kids: fun or flop?
NCT ID NCT07368400
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a gamified mobile app can help 46 boys aged 6–12 with Duchenne muscular dystrophy stay motivated with their home physiotherapy. The app includes rewards, levels, and feedback to make exercise more engaging. Researchers will measure physical function, endurance, and well-being after 8 weeks and at 6 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Gamified mobile physiotherapy exercise application
- What this could lead to
- If it works, this could offer a fun, accessible way for children with Duchenne muscular dystrophy to stick with their home exercises and slow physical decline.
- What could go wrong
- This is a small, early-stage trial with only 46 participants, so results may not apply to all children. The app is a behavioral tool, not a treatment for the disease itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 46 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 12 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male child aged 6 to 12 years with a confirmed diagnosis of Duchenne muscular dystrophy (DMD) based on specialist evaluation and genetic testing. * Vignos lower extremity classification stage 1 or 2. * Brooke upper extremity functional classification at least stage 5. * Score of 27 or higher on the Modified Mini-Mental Test. * Ability to walk independently for at least 6 minutes. * Receiving physiotherapy and rehabilitation for at least 8 sessions over a 1-month period. * Having regular access to the internet at home. * Parent(s) or legal guardian willing to allow the child to participate and able to read and sign the written informed consent form. Exclusion Criteria: * Presence of any additional diagnosed neurological disorder other than, or in addition to, Duchenne muscular dystrophy. * History of any injury and/or surgery within the last 6 months. * Any cooperation or behavioral problem that prevents completion of the assessment procedures. * Difficulty in understanding or speaking Turkish.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Duchenne muscular dystrophy (DMD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Hour online class help families manage bladder and bowel issues in duchenne muscular dystrophy?
- Can a new drug help boys with duchenne muscular dystrophy build muscle protein?
- New drugs aim to slow muscle decline in duchenne muscular dystrophy
- AI-Powered heart scans aim to predict deadly complications in muscular dystrophy
- Wearable sensors could bring duchenne monitoring home
- Could a popular Weight-Loss drug help—or Harm—Those with duchenne muscular dystrophy?